Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KEVIN DALE ROWLEY

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1942456710
CMS profile
873783
Location
EL PASO, TX

General Payments · PY2018–2024

$4,366.52

  • Reported across 224 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$906.26

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $816.27 35
Education $89.99 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25.70 1
PY2019 $244.02 7
PY2020 $520.13 35
PY2021 $814.59 52
PY2022 $970.51 49
PY2023 $885.31 44
PY2024 $906.26 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $31.24 07/11/2024 Food and Beverage Undisputed 01/23/2026 1078916069 CMS
Amgen Inc. $19.37 02/01/2024 Food and Beverage Undisputed 01/23/2026 1111693200 CMS
AstraZeneca Pharmaceuticals LP $123.44 01/19/2024 Food and Beverage Undisputed 01/23/2026 1104207911 CMS
AstraZeneca Pharmaceuticals LP $14.57 01/19/2024 Food and Beverage Undisputed 01/23/2026 1105513225 CMS
AstraZeneca Pharmaceuticals LP $16.16 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104366941 CMS
AstraZeneca Pharmaceuticals LP $16.64 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105623211 CMS
AstraZeneca Pharmaceuticals LP $29.08 05/24/2024 Food and Beverage Undisputed 01/23/2026 1105728863 CMS
AstraZeneca Pharmaceuticals LP $15.13 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105472743 CMS
AstraZeneca Pharmaceuticals LP $14.61 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104661141 CMS
AstraZeneca Pharmaceuticals LP $18.90 11/13/2024 Food and Beverage Undisputed 01/23/2026 1104723185 CMS
AstraZeneca Pharmaceuticals LP $22.48 12/03/2024 Food and Beverage Undisputed 01/23/2026 1104664589 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.42 04/26/2024 Food and Beverage Undisputed 01/23/2026 1118244833 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.52 11/07/2024 Food and Beverage Undisputed 01/23/2026 1118244835 CMS
Eurofins Viracor, LLC $17.10 06/11/2024 Food and Beverage Undisputed 01/23/2026 1146398733 CMS
GENZYME CORPORATION $22.39 03/28/2024 Food and Beverage Undisputed 01/23/2026 1139745880 CMS
GENZYME CORPORATION $21.18 06/21/2024 Food and Beverage Undisputed 01/23/2026 1139745906 CMS
GENZYME CORPORATION $17.46 07/08/2024 Food and Beverage Undisputed 01/23/2026 1139745916 CMS
GENZYME CORPORATION $19.54 09/18/2024 Food and Beverage Undisputed 01/23/2026 1139745940 CMS
GENZYME CORPORATION $14.56 10/14/2024 Food and Beverage Undisputed 01/23/2026 1139745948 CMS
GENZYME CORPORATION $17.66 12/06/2024 Food and Beverage Undisputed 01/23/2026 1139745974 CMS
GlaxoSmithKline, LLC. $21.22 05/28/2024 Food and Beverage Undisputed 01/23/2026 1116545380 CMS
GlaxoSmithKline, LLC. $16.52 06/21/2024 Food and Beverage Undisputed 01/23/2026 1116720870 CMS
GlaxoSmithKline, LLC. $16.59 07/25/2024 Food and Beverage Undisputed 01/23/2026 1116644254 CMS
GlaxoSmithKline, LLC. $19.33 10/04/2024 Food and Beverage Undisputed 01/23/2026 1116450447 CMS
Grifols USA, LLC $19.12 02/27/2024 Food and Beverage Undisputed 01/23/2026 1124725252 CMS
Grifols USA, LLC $22.62 03/19/2024 Food and Beverage Undisputed 01/23/2026 1124725250 CMS
Grifols USA, LLC $19.02 10/23/2024 Food and Beverage Undisputed 01/23/2026 1124725254 CMS
Grifols USA, LLC $18.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 1124725256 CMS
Insmed, Inc. $22.63 10/01/2024 Food and Beverage Undisputed 01/23/2026 1089579780 CMS
Mylan Specialty L.P. $28.37 01/22/2024 Food and Beverage Undisputed 01/23/2026 1147327131 CMS
Mylan Specialty L.P. $33.74 10/02/2024 Food and Beverage Undisputed 01/23/2026 1147299723 CMS
Mylan Specialty L.P. $33.88 11/12/2024 Food and Beverage Undisputed 01/23/2026 1147313670 CMS
Novartis Pharmaceuticals Corporation $18.01 02/02/2024 Food and Beverage Undisputed 01/23/2026 1087236823 CMS
Novartis Pharmaceuticals Corporation $20.03 05/23/2024 Food and Beverage Undisputed 01/23/2026 1087236829 CMS
Novartis Pharmaceuticals Corporation $21.74 08/23/2024 Food and Beverage Undisputed 01/23/2026 1087236831 CMS
SANOFI-AVENTIS U.S. LLC $89.99 06/22/2024 Education Undisputed 01/23/2026 1139745904 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.